🇺🇸 FDA
Patent

US 8754080

Pyrimidine substituted purine compounds as kinase (S) inhibitors

granted A61KA61K31/5377A61P

Quick answer

US patent 8754080 (Pyrimidine substituted purine compounds as kinase (S) inhibitors) held by VERASTEM, INC. expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VERASTEM, INC.
Grant date
Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/5377, A61P, A61P1/00, A61P1/04